-The Hindu Business Line Will seek removal of restrictions in ‘peace clause' India has decided to strike a harder bargain on food security at the World Trade Organisation than it did in July. It wants restrictive conditions attached to the use of the peace clause dropped. New Delhi, which had wanted the ‘peace clause' offering protection against retaliatory action for breaching farm subsidy caps extended indefinitely in return for support to the trade...

-Asia News Network A controversy is brewing over a new cure for hepatitis C because it is extremely expensive and patients in middle-income countries like Malaysia will find it way beyond their budget. There are an estimated 400,000 Malaysians with hepatitis C, but this is probably a significant under-estimate since many people are not aware that they have the virus. Worldwide, 170 million people live with the hepatitis C virus (HCV), and every...

-The Telegraph The Supreme Court today agreed to take up "as early as possible" a plea challenging a recent NDA government decision that is alleged to have paved the way for a sharp rise in the prices of life-saving drugs. Petitioner Manohar Lal Sharma, a lawyer, has demanded a CBI probe into a September 22 government order that he says frees a list of medicines from pricing control. His public interest plea alleges...

-Tehelka Despite the serious toll it takes on women's health, female sterilisation remains the most prevalent form of contraception in India. While memories of the 21 months of Emergency in 1975-77, imposed by the then prime minister Indira Gandhi, survives even today in the minds of Indian men as the fear of forced sterilisation, the country's population control policies have shifted over the years since then to target the politically less...

-DNA The Union government decision to decontrol prices of 108 drugs -- used to treat tuberculosis, AidS, diabetes and heart ailments -- has jacked up their prices. In some cases, prices have seen an unbelievable rise. The price of Glivec, an anti-cancer tablet, for example, has risen from Rs 8,500 to Rs 1.08 lakh. Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615, against the earlier Rs 147. An...